mesalamine has been researched along with Autoimmune Chronic Hepatitis in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ter Avest, MM | 1 |
| van Hee, K | 1 |
| Bronkhorst, C | 1 |
| de Jonge, HJM | 1 |
| Kondo, H | 1 |
| Watanabe, J | 1 |
| Iwasaki, H | 1 |
2 other studies available for mesalamine and Autoimmune Chronic Hepatitis
| Article | Year |
|---|---|
Mesalazine induced autoimmune hepatitis in a patient with Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Hepatitis, Autoimmune; Humans; Mesalamine | 2021 |
T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Gene Rearrangement; Genes, T-Cell Receptor beta; Hepa | 2001 |